Establishing the President's Commission on Combating Drug Addiction and the Opioid Crisis
Signed March 29, 2017·Donald Trump·82 FR 16283
Source
Everything on this page is drawn from the Federal Register, the official daily journal of the United States government. Where this page and the source disagree, the source governs.
Plain-language summary
Establishes the President's Commission on Combating Drug Addiction and the Opioid Crisis, made up of members appointed by the President, with a chair designated from among them. The commission is tasked with studying the federal response to drug addiction and opioid abuse, including reviewing existing federal funding, assessing access to treatment and overdose-reversal services, examining prevention practices and prescription monitoring programs, evaluating educational messaging, and reviewing existing federal programs, then recommending improvements to the President. The Office of National Drug Control Policy will provide administrative support and funding to the extent permitted by law. The commission must submit an interim report within 90 days of the order and a final report by October 1, 2017, unless the chair notifies the President that an extension is needed. The commission will terminate 30 days after submitting its final report unless the President extends it. Members serve without extra pay, though private citizens may receive travel expenses.
Not written or reviewed by a person. Read the full order below for anything you intend to rely on.
Report a problem with this summary
Legal standing
Not yet published. Court challenges, injunctions and rulings tied to individual orders will appear here once each can be linked to its source record.
Nothing appears in this space without a citation to a court action or a cited precedent. An order with no such record is described as untested, never as likely or unlikely to survive.
Claimed authority
By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered
Quoted from the order as written. Many orders cite nothing more specific than “the Constitution and the laws”; this reproduces what the order claims, not an assessment of whether it holds.
The order, in full
Executive Order 13784 of March 29, 2017
Establishing the President's Commission on
Combating Drug Addiction and the Opioid Crisis
By the authority vested in me as President by the
Constitution and the laws of the United States of
America, it is hereby ordered as follows:
Section 1. Policy. It shall be the policy of the
executive branch to combat the scourge of drug abuse,
addiction, and overdose (drug addiction), including
opioid abuse, addiction, and overdose (opioid crisis).
This public health crisis was responsible for more than
50,000 deaths in 2015 alone, most of which involved an
opioid, and has caused families and communities across
America to endure significant pain, suffering, and
financial harm.
Sec. 2. Establishment of Commission. There is
established the President's Commission on Combating
Drug Addiction and the Opioid Crisis (Commission).
Sec. 3. Membership of Commission. (a) The Commission
shall be composed of members designated or appointed by
the President.
(b) The members of the Commission shall be selected
so that membership is fairly balanced in terms of the
points of view represented and the functions to be
performed by the Commission.
(c) The President shall designate the Chair of the
Commission (Chair) from among the Commission's members.
Sec. 4. Mission of Commission. The mission of the
Commission shall be to study the scope and
effectiveness of the Federal response to drug addiction
and the opioid crisis described in section 1 of this
order and to make recommendations to the President for
improving that response. The Commission shall:
(a) identify and describe existing Federal funding
used to combat drug addiction and the opioid crisis;
(b) assess the availability and accessibility of
drug addiction treatment services and overdose reversal
throughout the country and identify areas that are
underserved;
(c) identify and report on best practices for
addiction prevention, including healthcare provider
education and evaluation of prescription practices, and
the use and effectiveness of State prescription drug
monitoring programs;
(d) review the literature evaluating the
effectiveness of educational messages for youth and
adults with respect to prescription and illicit
opioids;
(e) identify and evaluate existing Federal programs
to prevent and treat drug addiction for their scope and
effectiveness, and make recommendations for improving
these programs; and
(f) make recommendations to the President for
improving the Federal response to drug addiction and
the opioid crisis.
Sec. 5. Administration of Commission. (a) The Office of
National Drug Control Policy (ONDCP) shall, to the
extent permitted by law, provide administrative support
for the Commission.
(b) Members of the Commission shall serve without
any additional compensation for their work on the
Commission. Members of the Commission appointed from
among private citizens of the United States, while
engaged in the work of the Commission, may be allowed
travel expenses, including
per diem in lieu of subsistence, to the extent
permitted by law for persons serving intermittently in
Government service (5 U.S.C. 5701-5707), consistent
with the availability of funds.
(c) Insofar as the Federal Advisory Committee Act,
as amended (5 U.S.C. App.) (Act), may apply to the
Commission, any functions of the President under that
Act, except for those in section 6 and section 14 of
that Act, shall be performed by the Director of the
ONDCP, in accordance with the guidelines that have been
issued by the Administrator of General Services.
Sec. 6. Funding of Commission. The ONDCP shall, to the
extent permitted by law and consistent with the need
for funding determined by the President, make funds
appropriated to the ONDCP available to pay the costs of
the activities of the Commission.
Sec. 7. Reports of Commission. Within 90 days of the
date of this order, the Commission shall submit to the
President a report on its interim recommendations
regarding how the Federal Government can address drug
addiction and the opioid crisis described in section 1
of this order, and shall submit a report containing its
final findings and recommendations by October 1, 2017,
unless the Chair provides written notice to the
President that an extension is necessary.
Sec. 8. Termination of Commission. The Commission shall
terminate 30 days after submitting its final report,
unless extended by the President prior to that date.
Sec. 9. General Provisions. (a) Nothing in this order
shall be construed to impair or otherwise affect:
(i) the authority granted by law to an executive department or agency, or
the head thereof; or
(ii) the functions of the Director of the Office of Management and Budget
relating to budgetary, administrative, or legislative proposals.
(b) This order shall be implemented consistent with
applicable law and subject to the availability of
appropriations.
(c) This order is not intended to, and does not,
create any right or benefit, substantive or procedural,
enforceable at law or in equity by any party against
the United States, its departments, agencies, or
entities, its officers, employees, or agents, or any
other person.
(Presidential Sig.)
THE WHITE HOUSE,
March 29, 2017.Reproduced from the Federal Register plain-text record, signed March 29, 2017. Typesetting artifacts are removed; no wording is changed.